|

ZG2001 Tosilate Tablets Clinical Trials

1 actively recruiting trial

Also known as: ZG2001

Pipeline

Phase 1/2: 1

Top Sponsors

  • Suzhou Zelgen Biopharmaceuticals Co.,Ltd1

Indications

  • KRAS Mutation-Related Tumors1
  • Solid Tumor1
  • Cancer1

Other1 trial

A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid Tumours
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.